{"schema_version":"secwatch.filing_event.v1","accession":"0001140361-23-029970","form_type":"8-K","ticker":"FEMY","cik":"0001339005","company_name":"FEMASYS INC","filed_at":"2023-06-15T23:59:59+00:00","discovered_at":"2026-05-14T18:03:38.501612+00:00","generated_at":"2026-06-13T23:53:51.960885+00:00","sec_items":["5.02","8.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Femasys appoints Kendall and Milnes to board, replacing Dyett and Adams","bullets":["John Dyett and John Adams resigned from board effective June 14, 2023; no disagreement with company.","Keith Kendall (former CEO/President/CFO of Aquestive Therapeutics) appointed Class III director and Audit Committee Chair.","Alistair Milnes (COO of Bicycle Therapeutics) appointed Class I director, serves on Audit and Nominating Committees.","Anne Morrisey resigned from Audit Committee effective June 14, 2023.","New directors entitled to standard annual retainer and equity awards under company policy."],"urls":{"canonical":"https://secwatch.observer/filing/0001140361-23-029970","json":"https://secwatch.observer/filing/0001140361-23-029970.json","markdown":"https://secwatch.observer/filing/0001140361-23-029970.md","text":"https://secwatch.observer/filing/0001140361-23-029970.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1339005/000114036123029970/0001140361-23-029970-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1339005/000114036123029970/brhc20054453_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-13T23:53:51.960885+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"62cde49251","claim":"John Dyett resigned as Director at FEMASYS INC.","evidence_excerpt":"Effective June 14, 2023, the Board of Directors of Femasys Inc. (the “Company”) accepted John Dyett and John Adams’s resignation from the Board of Directors.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1339005/000114036123029970/0001140361-23-029970-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"7e423e3bbd","claim":"Alistair Milnes was appointed as Director at FEMASYS INC.","evidence_excerpt":"In connection with Messrs. Dyett and Adams’s resignations, the Board of Directors appointed Keith J. Kendall and Alistair Milnes as directors of the Company.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1339005/000114036123029970/0001140361-23-029970-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"8e6b945c27","claim":"Keith J. Kendall was appointed as Director at FEMASYS INC.","evidence_excerpt":"In connection with Messrs. Dyett and Adams’s resignations, the Board of Directors appointed Keith J. Kendall and Alistair Milnes as directors of the Company.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1339005/000114036123029970/0001140361-23-029970-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"da3b0954a1","claim":"John Adams resigned as Director at FEMASYS INC.","evidence_excerpt":"Effective June 14, 2023, the Board of Directors of Femasys Inc. (the “Company”) accepted John Dyett and John Adams’s resignation from the Board of Directors.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1339005/000114036123029970/0001140361-23-029970-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}